Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CYCN

Cyclerion Therapeutics Inc

May 15 • 02:17PM ET

3.11

+0.02 0.65 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BIVI PRQR LCTX PALI BCDA

| Held by: ONEQ VXF DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.37	Insider Own	27.95%	Shs Outstand	4.24M	Perf Week	0.32%
Market Cap	13.47M	Forward P/E	-	EPS next Y	-0.99	Insider Trans	0.00%	Shs Float	3.12M	Perf Month	4.36%
Enterprise Value	10.65M	PEG	-	EPS next Q	-	Inst Own	19.56%	Short Float	1.81%	Perf Quarter	148.80%
Income	-5.28M	P/S	6.77	EPS this Y	10.45%	Inst Trans	1.70%	Short Ratio	0.01	Perf Half Y	119.01%
Sales	1.99M	P/B	1.94	EPS next Y	17.50%	ROA	-57.50%	Short Interest	0.06M	Perf YTD	144.88%
Book/sh	1.60	P/C	4.78	EPS next 5Y	-	ROE	-67.77%	52W High	8.48 -63.33%	Perf Year	6.57%
Cash/sh	0.65	P/FCF	-	EPS past 3/5Y	62.04% 53.53%	ROIC	-77.69%	52W Low	1.03 202.94%	Perf 3Y	-18.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	91.14% -2.01%	Gross Margin	-	Volatility	4.58% 5.93%	Perf 5Y	-94.71%
Dividend TTM	-	EV/Sales	5.35	EPS Y/Y TTM	-17.96%	Oper. Margin	-337.43%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.80	Sales Y/Y TTM	-4.23%	Profit Margin	-264.73%	RSI (14)	52.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.80	EPS Q/Q	-35.13%	SMA20	-0.34%	Beta	1.80	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	16.25%	Rel Volume	0.01	Prev Close	3.09
Employees	1	LT Debt/Eq	0.00	Earnings	Mar 25	SMA200	49.82%	Avg Volume	4.65M	Price	3.11
IPO	Mar 18, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	30,502	Change	0.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)